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Abstract 
Background: Translational research to develop pharmaceutical and surgical treatments for pterygium requires a reli‑
able and easy to produce animal model. Extracellular matrix and fibroblast are important components of pterygium. 
The aim of this study was to analyze the effect of the subconjunctival injection of fibroblast cells (NIH3T3 cell line) and 
exogenous extracellular matrix in rabbits in producing a pterygium‑like lesion.
Methods: Six 3‑month‑old white New Zealand rabbits were injected with 20,000 NIH3T3 cells and 5 µL of Matrigel 
in the right conjunctiva, and with only 5 µL of Matrigel in the left conjunctiva. The eyes were photographed under a 
magnification of 16× using a 12‑megapixel digital camera attached to the microscope on day 1, 3 and 7. Conjunctival 
vascularization was measured by analyzing images to measure red pixel saturation. Area of corneal and conjunctival 
fibrovascular tissue formation on the site of injection was assessed by analyzing the images on day 3 and 7 using area 
measurement software. Histopathologic characteristics were determined in the rabbit tissues and compared with a 
human primary pterygium.
Results: The two treatments promoted growth of conjunctival fibrovascular tissue at day 7. The red pixel saturation 
and area of fibrovascular tissue developed was significantly higher in right eyes (p < 0.05). Tissues from both treat‑
ments showed neovascularization in lesser extent to that observed in human pterygium. Acanthosis, stromal inflam‑
mation, and edema were found in tissues of both treatments. No elastosis was found in either treatment.
Conclusions: Matrigel alone or in combination with NIH3T3 cells injected into the rabbits’ conjunctiva can promote 
tissue growth with characteristics of human pterygium, including neovascularization, acanthosis, stromal inflamma‑
tion, and edema. The combination of Matrigel with NIH3T3 cells seems to have an additive effect on the size and 
redness of the pterygium‑like tissue developed.
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Background
Pterygium is a benign fibrovascular growth of the ocu-
lar surface commonly associated to discomfort and 
red eye, and as disease progresses is often related to 
decreased vision (topographic astigmatism) and ocular 
motility restriction in severe cases [1]. A wide variety 
of pro-inflammatory cytokines induced by fibrogenic 
growth factors, oxidative stress and DNA methylation 
have been implicated in the pathogenesis of pterygium. 
Since some of these factors are affected by exposure to 
ultraviolet (UV) light, current evidence from multiple 
sources suggests that individuals with high exposure to 
sunlight are at increased risk of pterygium [2]. Despite 
the extensive research, there is no clear understanding 
of the pathogenesis of pterygium, but one of the most 
important factors contributing to the pathogenesis are 
the neoplastic changes of limbal stem cells associated 
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to UV light exposure and the possible role of oncogenic 
virus (Human papillomavirus) [3].
Epidemiological studies report that the prevalence of 
pterygium in Latino population is elevated (16% overall), 
especially in people with low income and low educational 
status, increased age and with men having a higher preva-
lence compared to female (2:1) [4]. The definite treatment 
is often surgical excision with the use of adjuvant anti-
proliferative drugs (mitomycin C, 5-fluorouracil, doxycy-
cline or bevacizumab), which still need standardization 
and, in the best scenario, still report variable recurrence 
rates (0.1–33.3%) [5–7]. In  vitro models focused on the 
pathogenesis of pterygium to explore the intercellular 
signaling pathways in epithelial cells and fibroblasts show 
promising results [8, 9], but animal models to support the 
evidence are needed. To date, three animal models for 
pterygium have been described, using injection of human 
epithelial pterygium cells, exogenous extracellular matrix 
or UV scattered radiation in rabbit and mice [3, 10, 11]. 
The results of the rabbit model using UV scattered light 
are focused on the computational prediction of the size 
and shape of the tissue growth, with no histological 
analysis. The mouse model showed histological charac-
teristics of human pterygium, however, manipulation of 
rabbits for ophthalmological procedures is easier given 
that the ocular structure and size resembles more to that 
of human.
Hence, the purpose of this study was to develop an ani-
mal model for pterygium using subconjunctival injection 
of murine fibroblast cells (NIH 3T3 cell line) and exog-
enous extracellular matrix (Matrigel) in white New Zea-
land rabbits suitable for its implementation on both basic 
pharmacologic/molecular research on pterygium patho-
genesis and on novel surgical techniques.
Methods
All procedures were conducted according to the Guide 
for the Care and Use of Laboratory Animals and were 
approved by Institutional Animal Care and Use Com-
mittee. A total of six 3-month-old white New Zealand 
rabbits were used. Animals were anesthetized with 
intramuscular injection of ketamine HCl (30  mg/kg) 
and xylazine (5  mg/kg) and topical anesthesia with tet-
racaine hydrochloride (2 eye drops). Rabbits received 
subconjunctival injection of 20,000 murine fibroblast 
cells (NIH 3T3 cell line) and 5  µL of Matrigel (Corning 
Inc., New York, US) on the perilimbal temporal bulbar 
conjunctiva of the right eye using a 1 ml 30G needle. Left 
eyes were injected with 5 µL of Matrigel under the per-
ilimbal temporal bulbar conjunctiva (control). The eyes 
were photographed under a magnification of 16× using a 
12-megapixel digital camera attached to the microscope 
(World Precision Instruments, Inc. FL, US) on day 1, 3 
and 7. Conjunctival vascularization was measured on day 
1, 3 and 7 by analyzing images using Adobe Photoshop 
CS5 (Version 12.0, Adobe, San Jose, CA) color histo-
grams to measure red pixel saturation on a 6 × 6 mm area 
on the site of injection. Area of corneal and conjunctival 
fibrovascular tissue formation on the site of injection and 
surrounding area was assessed by analyzing the images 
on day 3 and 7 using area measurement software (Adobe 
Photoshop CS5).
After 7  days, surgical specimens were obtained under 
anesthesia and were immediately fixed in 10% buffered 
formalin (pH = 7.3) for at least 8  h, routine histopatho-
logic process was followed and tissue was embedded in 
paraffin. Immediately after obtaining conjunctival speci-
mens, all rabbits were euthanized (day 7) using a lethal 
dose (200  mg/kg) of intravenously-administered pento-
barbital (Penta-Hypnol®, Agrovet MArket, Lima, Peru). 
Each sample was serially cut into at least 10 four micron-
thick sections, mounted and stained with hematoxylin/
eosin staining method. All specimens were evaluated by 
the same pathologist to limit subjective variation during 
the observation and counting process. Histopathologic 
characteristics including neovascularization, epithelial 
inflammation, stromal inflammation, acanthosis, elasto-
sis and edema were determined in the rabbit tissues and 
compared with a human primary pterygium.
Histological changes were semi-quantitatively clas-
sified into six groups. Vascular density was defined as 
the average vessel count in six high power fields (HPF, 
400×) in the areas appearing as the most vascularized 
foci. The whole pterygium specimen was examined and 6 
HPF which seemed to have the greatest vascular density 
were selected; all vessels lined by endothelium were con-
sidered, given that the presence of endothelium makes 
it possible to differentiate a vessel from the pseudo-vas-
cular canal. Epithelial and stromal inflammation were 
graded with the following scale: grade 0, absent or sparse 
inflammatory cells in the tissue; and grade 1, significant 
patchy or diffuse inflammatory cells infiltration. Acan-
thosis was graded based on the number of epithelial cells 
found (N) in the unaltered epithelium, using the follow-
ing scale: grade 0, absent or any number smaller than N; 
grade 1, N – 1½N; and grade 2, 1½N – 2 N. The percent-
age of elastosis and edema were described as the propor-
tion of elastotic changes and edema, respectively, to the 
whole fibro connective stroma and graded with the fol-
lowing scale: grade 0, absent; grade 1, element found on 
less than 50% of the tissue; and grade 2, element found 
on more than 50% of the tissue. The sections were ana-
lyzed using standard light microscopy (Carl Zeiss, Axi-
ostar plus, Germany) under 400× and 40× magnification 
for vascular density, epithelial and stromal inflammation, 
and acanthosis; and elastosis and edema, respectively. 
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Statistical analysis was performed using paired t-test 
and analysis of variance (ANOVA) for mean compari-
sons, statistical significance was considered with a p 
value < 0.05.
Results
All eyes (12 eyes) of the 6 rabbits developed conjuncti-
val fibrovascular tissue after injection of Matrigel and 
NIH3T3 cells (n = 6, right eyes) or only Matrigel (n = 6, 
left eyes) at day 7 (Fig. 1). The mean area of fibrovascular 
tissue developed in the right eyes at day 1, 3 and 7 was 
2.92 ± 1.21, 14.32 ± 3.47 and 33.97 ± 4.40  mm2 respec-
tively. Left eyes had a mean fibrovascular tissue area of 
2.91 ± 1.36, 8.41 ± 2.08 and 15.36 ± 3.89 mm2 at days 1, 3 
and 7 respectively. The difference in fibrovascular growth 
areas observed between right and left eyes at day 3 and 7 
was significant (p < 0.05) (Fig. 2). A significant increase in 
fibrovascular growth was also observed between days 1 
and 3 (p = 0.001), days 1 and 7 (p < 0.001) and days 3 and 
7 (p < 0.001) in right eyes. Likewise, a significant increase 
in fibrovascular growth was also observed between days 1 
and 3 (p = 0.006), days 1 and 7 (p = 0.001) and days 3 and 
7 (p = 0.001) in left eyes. No difference was seen between 
red pixel saturation of the fibrovascular tissue in right 
and left eyes at day 1 and 3. At day 7, right eyes exhib-
ited significant (p < 0.05) higher red pixel saturation of 
the developed fibrovascular tissue, related to conjunctival 
vascularization, when compared with left eyes (Fig. 3).
Significant differences in the neovascularization pat-
tern between rabbit induced pterygium tissue and human 
pterygium was observed in the histopathological analysis 
(Table 1). The average number of vessels found in the 6 
analyzed lamellas of the right eyes was 29, while in the 
left eyes was 27; which is far from the 134 found in the 
human tissue. Five eyes of each treatment (right and left 
eyes) registered non- epithelial inflammation, resem-
bling the changes observed in human pterygium. Stromal 
inflammation, absent in human pterygium, was observed 
in 1 of 6 right eyes and in 4 of the 6 left eyes. Acantho-
sis was observed in 4 right eyes and in 6 left eyes (Posi-
tive, grade 2 in human pterygium sample). Only one eye 
in each group (Matrigel + NIH 3T3 and Matrigel alone) 
Fig. 1 Right eye of rabbit 4 at 1, 3 and 7 days (a, b and c respectively) post injection of Matrigel and NIH3T3; left eye of rabbit 4 at 1, 3 and 7 days (d, 
e and f respectively) post injection of Matrigel only
Fig. 2 Analysis of the difference between the fibrovascular growth 
areas  (mm2) observed at day 1, 3 and 7, post injection site in the 
animal model right (n = 6) and left eyes (n = 6) (6 rabbits, 12 eyes)
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showed elastosis in the same grade as human pterygium, 
while edema was observed in a similar grade between 
all right eyes specimens and human pterygium. Three 
left eyes showed grade 1 edema and three showed grade 
2 edema. Figure  4 shows a representative image of the 
fibrovascular tissue developed in one rabbit (right eye, 
Matrigel + NIH 3T3) and the human pterygium.
Discussion
Pterygium is a frequent ophthalmological disease whose 
pathogenesis is not fully understood. The only defini-
tive treatment available is surgical excision, with the dis-
advantage of a variable but persistent recurrence rate. 
Surgical alternatives and novel approaches involving 
autologous conjunctival grafts, extensive Tenon’s resec-
tion and amniotic membrane transplant in the excision 
area combined with the use of postsurgical antimetabo-
lites to decrease the recurrence rate have shown promis-
ing results [5, 7]. However, the lack of knowledge about 
the subjacent molecular and cellular mechanisms have 
hindered the development of novel pharmacological 
treatments and therapeutic approaches. Consequently, 
the development of a pterygium animal model is an 
essential tool in the research for pathogenic events and 
novel surgical and pharmacological approaches.
Fig. 3 Red pixel saturation comparison analysis at day 1, 3 and 7, 
animal model right (n = 6) and left eyes (n = 6) (6 rabbits, 12 eyes)
Table 1 Comparison of the tissue characteristics of 13 lamellae, corresponding to the 6 right and 6 left eyes after 7 days 
of injection and a human pterygium
RE right eye, LE left eye
Eye Rabbit 1 Rabbit 2 Rabbit 3 Rabbit 4 Rabbit 5 Rabbit 6 Human
RE LE RE LE RE LE RE LE RE LE RE LE
Neovascularization 21 30 30 18 17 54 30 20 46 19 31 23 134
Epithelial inflammation 0 1 0 0 0 0 1 0 0 0 0 0 0
Stromal inflammation 1 1 1 0 0 0 1 0 1 0 1 1 0
Acanthosis 2 2 0 2 0 2 2 2 2 2 2 2 2
Elastosis 0 0 0 1 1 0 0 0 0 0 0 0 1
Edema 2 2 2 2 2 1 2 1 2 1 2 2 2
Fig. 4 Comparison of the histopathological criteria evaluated in human pterygium a and the rabbit conjunctival fibrovascular tissue in a right eye 
b. Fibroconnective tissue (asterisk) is observed with a great amount of blood vessel (open triangle) coated by acanthotic squamous epithelium 
(filled triangle). In the rabbit tissue, edema interstitial is observed but not in human pterygium (H&E ×100)
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Previous attempts in developing a rabbit models for 
pterygium were carried out by Kowk and Coroneo [3], 
who reported the use of incident ultraviolet (UV) scat-
tered light at the temporal limbus to induce a predicted 
shaped and sized pterygium-like growth. Although this 
model reproduces the real UV light stimulation that is 
hypothesized to play a biologic key role in pterygium 
pathogenesis, the conjunctival/limbal stimulation with 
UV light required to produce significant conjunctival 
epithelial proliferation would be extensive, hence the 
need of a computational algorithm to simulate the pre-
dicted growth and final shape. Moreover, no histological 
analysis was reported to register the characteristics of the 
induced tissue growth.
In a different research, 6 week old athymic nude mice 
were used to induce pterygium with an injection of 
1 × 104 human epithelial pterygium cells followed by an 
injection of chondrocyte derived extracellular matrix 7, 
10 or 14 days after the epithelial cell injection [11]. At day 
17, a lesion growth was observed with higher significant 
size in the eyes injected with only epithelial cells than that 
observed in the eyes injected with cells and extracellular 
matrix. Their histological analysis revealed epithelial cells 
extending into the superficial stroma, neo-vessels, and 
extracellular matrix breakdown in the eyes injected with 
epithelial cells, but not in those injected with extracellu-
lar matrix. Similarly, Cox et  al. used conjunctival injec-
tion with 1 × 104 human epithelial pterygium cells mixed 
with 5 μL of Matrigel on nude athymic mice, observing a 
lesion growth on the injection site after 6 days [10]. They 
reported no lesion growth in mice injected with only 
Matrigel. In the histological analysis, neovascularization 
and migrating cells could be seen only in the epithelial 
cell injected mice conjunctivas.
Our model was conducted on young White New Zea-
land rabbits, an animal model that shares similarities 
with human ocular structure including size, thus pro-
viding an advantage over the surgical manipulation and 
the extent of pterygium-like tissue developed useful for 
further analysis. In our study, we compared the effect of 
the conjunctival injection of only Matrigel, in left eyes, 
and Matrigel with NIH3T3 fibroblasts, in right eyes. The 
concentration of injected cells and volume of Matrigel 
was the same used by Yang and Cox [10, 11]. Although 
following similar methods, Yang et  al. [11] decided to 
wait until day 17 after injection to perform the histologic 
examination since it was only then when they observed 
a significant difference in the lesion size between their 
groups (eyes with only epithelial fibroblasts cells com-
pared to the injection of extracellular matrix and cells). 
On the other hand, as evidenced on Fig. 2, we observed 
a significant difference in the lesion size since day 3 post 
injection between right eyes (NIH 3T3 cell + Matrigel) 
and left eyes (Matrigel). Hence, we decided to per-
form the histologic examination as early as day 7 post 
injection. However, relevant data and observations can 
emerge from future protocols assessing the histological 
characteristics between the lesions in different post injec-
tion times.
Although both Matrigel and chondrocyte derived 
extracellular matrix are used to promote cell prolifera-
tion, the former is known for its gel composition at room 
temperature containing bFGF, IGF, EGF, laminin, colla-
gen 1, and heparin sulfate proteoglycan [12], which exerts 
a slow release characteristic that favors angiogenesis [13–
16]. In the mice model injected with Matrigel reported by 
Cox, there was no tissue growth at day 6. Our model sug-
gests that the combination of NIH3T3 cells (an immor-
talized mouse fibroblast line) with Matrigel, enhances the 
growth of the pterygium-like tissue. This was confirmed 
by the macroscopic clinical analysis performed to assess 
red-pixel saturation, which can correlate to hyperemia, 
neovascularization and other histological events; and tis-
sue growth area measured in square millimeters.
A histological analysis using a scale of 6 parameters 
commonly observed in human pterygium [17–20] was 
carried out. The most distinctive feature of human 
pterygium is neovascularization [19, 21]. In our analysis, 
tissues of both groups showed neovascularization with a 
slight increased level in right eyes, but in a lower grade 
than that observed in human pterygium [20]. Nonethe-
less, the number of new vessels in human pterygium has 
been reported as extremely variable [19, 20]. In human 
pterygium, redness and fleshiness are correlated with the 
vascular density and stromal fibrosis, while the extent 
of the pterygium over the cornea has an inverse relation 
with the stromal elastosis [18]. This is in accordance with 
our results, in which higher redness and vascularization 
was observed in right eyes. No invasion over the cornea 
was observed after 7 days, further experiments analyzing 
the growth of the tissue over a longer period will provide 
information about the correlation of this parameter and 
the stromal elastosis level observed.
No epithelial inflammation was seen in the tissue 
induced in right or left eyes, paralleling the histopa-
thology of primary human pterygium. Elastosis was 
seen only in one eye of each treatment group. The latter 
parameter is highly associated to chronic UV radiation 
exposure [17], and it is reported as a key histological 
characteristic in primary pterygium and minimal in 
recurrent pterygium [20]. The absence of significant 
elastotic changes in the analyzed tissues could be asso-
ciated with the method used to induce the pterygium-
like tissue formation (eliciting inflammatory immune 
response and/or fibroblastic cell proliferation, not asso-
ciated with UV light exposure) and to the short period 
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after which histological analysis was performed. Oth-
erwise, cellular edema was similar between right eyes 
and human pterygium, comparable with the observa-
tions of previous reports [19]. Although similar proto-
cols in mice models [10, 11] have succeeded in eliciting 
and inflammatory response and tissue growth over the 
injection site (subconjunctival), histologic descrip-
tions when available, have only shown neo-vessels, cell 
migration and extracellular matrix breakdown with no 
evidence of acanthosis, elastosis or stromal/epithelial 
inflammation.
Conclusions
In conclusion, Matrigel alone or in combination with 
NIH3T3 cells injected into the rabbit conjunctiva can 
promote tissue growth with clinical and histological 
characteristics like those of human pterygium, includ-
ing neovascularization, acanthosis, stromal inflamma-
tion, and edema. The combination of Matrigel with 
NIH3T3 cells seems to have an additive effect on the 
size and redness of the pterygium-like tissue developed. 
The presented animal model combines successfully the 
formation of vascular conjunctival lesion with the con-
venient size of the rabbit eye, making it suitable for its 
implementation on both basic pharmacologic/molecular 
research on pterygium pathogenesis and on novel surgi-
cal techniques.
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